Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 43598-427

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 43598-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of decitabine showing its molecular arrangement with numbered atoms and functional groups, including nitrogenous bases and sugar moiety, consistent with its identity as the active ingredient decitabine.*

FDA Label Image

Vial (Vial)

Label for Decitabine Injection, 50 mg per vial, powder, lyophilized for solution for intravenous use. The label indicates it is a cytotoxic agent from Dr. Reddy's Laboratories Inc., with a single-dose sterile vial. Includes instructions to dilute before use and a barcode for product identification.*

FDA Label Image

Carton (Carton)

Decitabine For Injection 50 mg per vial, lyophilized powder for solution for intravenous use, by Dr. Reddy's Laboratories Inc. The carton label shows the proprietary name PREMIER ProRx with warnings for cytotoxicity, dilution instructions, and dosage form. It specifies single-dose vial use and includes barcodes, manufacturer and distributor information, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.